Black Diamond Therapeutics, Inc. (BDTX) vs VAXART, INC. (VXRT)
- Black Diamond Therapeutics, Inc. BDTX 1.73 +4.22%
- VAXART, INC. VXRT 0.37 0.00%
Black Diamond Therapeutics, Inc. and VAXART, INC. are both Biotechnology companies. Black Diamond Therapeutics, Inc. and VAXART, INC. are of similar size ($95.4M and $92.4M). Black Diamond Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. VAXART, INC. has the higher net margin (16.0% vs 0.00%) and the higher return on invested capital (2,542.3% vs 0.00%). Across the 14 metrics below, VAXART, INC. leads on 9 and Black Diamond Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | BDTX | VXRT | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 68.51% |
| Operating margin | 0.00% | 16.63% | 0.00% |
| Net margin | 0.00% | 16.02% | 0.00% |
| Free cash flow margin | 0.00% | 17.64% | 0.00% |
| Return on equity | (37.21%) | 62.42% | (51.96%) |
| Return on assets | (29.21%) | 16.26% | (46.06%) |
| Return on invested capital | 0.00% | 2,542.26% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack